Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07817563) titled 'Study Evaluating 68GA-FAPI-46 PET/CT in Patients With Interstitial Lung Disease' on Sept. 8.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Diagnostic. Masking: None (Open Label).

Primary Sponsor: Mayo Clinic

Condition: Interstitial Lung Disease

Intervention: Drug: 68Ga-FAPI-46

Recruitment Status: Not recruiting

Phase: Phase 1

Date of First Enrollment: October 16, 2026

Target Sample Size: 10

Countries of Recruitment: United States

To know more, visit https://clinicaltrials.gov/study/NCT07817563

Published by HT Digital Content S...